Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection

Am J Kidney Dis. 2022 Apr;79(4):480-482. doi: 10.1053/j.ajkd.2022.01.001. Epub 2022 Jan 12.

Authors

Steven Fishbane¹, Jamie S Hirsch², Vinay Nair²

Affiliations

¹ Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra / Northwell, Great Neck, New York. Electronic address: sfishbane@northwell.edu.
² Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra / Northwell, Great Neck, New York.

No abstract available

Publication types

Editorial

MeSH terms

COVID-19*
Drug Combinations
Humans
Kidney Transplantation*
Lactams
Leucine
Nitriles
Proline
Ritonavir
SARS-CoV-2
Transplant Recipients

Substances

Drug Combinations
Lactams
Nitriles
nirmatrelvir and ritonavir drug combination
Proline
Leucine
Ritonavir